fatty liver

(redirected from Alcoholic fatty liver)
Also found in: Thesaurus, Medical, Acronyms.
Related to Alcoholic fatty liver: Alcoholic hepatitis
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.fatty liver - yellow discoloration as a result of the accumulation of certain fats (triglycerides) in the liver; can be caused by alcoholic cirrhosis or pregnancy or exposure to certain toxins
liver disease - a disease affecting the liver
References in periodicals archive ?
Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl(4)-induced liver injury in rats with non alcoholic fatty liver disease.
The report provides comprehensive information on the therapeutics under development for Non Alcoholic Fatty Liver Disease (NAFLD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Clinical and histologic spectrum of non- alcoholic fatty liver disease associated with normal ALT values.
Of these, 162 had non- alcoholic fatty liver and 173 did not have this condition.
In the study, the researchers examined expression levels of proteins in liver biopsies from a group of patients with alcoholic fatty liver disease and a group with non-alcoholic fatty liver disease.
To study the prevalence of non alcoholic fatty liver disease and its correlation with metabolic syndrome.
Singh, "Imaging of non alcoholic fatty liver disease: A road less travelled," Indian Journal of Endocrinology and Metabolism, vol.
Objective: To compare serum lipid profile in different ultrasonographic grades of non alcoholic fatty liver disease (NAFLD).
His presentation was on Non Alcoholic Fatty Liver Disease (NAFLD) which was an excellent detailed review of the subject.
[USPRwire, Tue Mar 17 2015] GlobalData's clinical trial report, "Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015" provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario.
[ClickPress, Wed Aug 27 2014] Global Markets Direct's, 'Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2014', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD)'s therapeutic pipeline.
KEY WORDS: Aminotransferases, Dyslipidemia, Green tea extract, Non alcoholic fatty liver disease.